EICHOR
● Completed
Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM
Condition: Glioblastoma Multiforme · Sponsor: NovoCure Ltd.
About this study
To test the effectiveness and safety of Optune® given concomitantly with radiation therapy (RT) and temozolomide (TMZ) in newly diagnosed GBM patients, compared to radiation therapy and temozolomide alone. In both arms, Optune® and maintenance temozolomide are continued following radiation therapy.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (133)
| Grandview Cancer Center | Birmingham, Alabama, United States | — |
| Banner MD Anderson Cancer Center | Gilbert, Arizona, United States | — |
| Mayo Clinic- Arizona | Phoenix, Arizona, United States | — |
| University of Arizona Cancer Center | Tucson, Arizona, United States | — |
| Highlands Oncology Group | Fayetteville, Arkansas, United States | — |
| Providence St. Joseph Medical Center and The Roy and Patricia Disney Family Cancer Center | Burbank, California, United States | — |
| City of Hope National Medical Center | Duarte, California, United States | — |
| TRIO - St. Jude Heritage Healthcare/St. Jude Medical Center | Fullerton, California, United States | — |
| University of California at San Diego - Moores Cancer Center | La Jolla, California, United States | — |
| Norris Comprehensive Cancer Center at USC | Los Angeles, California, United States | — |
| Cedars - Sinai Medical Center | Los Angeles, California, United States | — |
| Hoag Memorial Hospital - Hoag Cancer Center | Newport Beach, California, United States | — |
+ 121 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04471844